Company Filing History:
Years Active: 1996-1999
Title: Innovations by Brenda E Reynolds
Introduction
Brenda E Reynolds is a notable inventor based in Guildford, GB. She has made significant contributions to the field of fatty acid treatments, particularly in relation to calcium absorption in humans and animals. With a total of three patents to her name, her work has implications for the treatment of osteoporosis.
Latest Patents
Brenda's latest patents focus on increasing gut calcium absorption through the administration of gamma-linolenic acid (GLA), dihomo-gamma-linolenic acid (DGLA), or linoleic acid (LA). These compounds can be administered in their natural forms or as salts and other pharmacologically acceptable forms. Additionally, her patents explore the potential benefits of associating these fatty acids with eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), or other essential fatty acids (EFA) to enhance their effectiveness in treating osteoporosis.
Career Highlights
Brenda E Reynolds has established herself as a key figure in her field, working with Scotia Holdings Plc. Her innovative approaches to fatty acid treatments have garnered attention and recognition within the scientific community.
Collaborations
One of her notable collaborators is David F Horrobin, with whom she has worked closely on various projects related to her patents.
Conclusion
Brenda E Reynolds continues to push the boundaries of innovation in the field of fatty acid treatments, contributing valuable research that may improve health outcomes for individuals suffering from osteoporosis. Her work exemplifies the impact of dedicated inventors in advancing medical science.